{
  "nodes": [
    {
      "id": "N1",
      "label": "Step 1",
      "customData": {
        "node_id": "A",
        "node_step_index": 0,
        "content": "39-year-old female Chinese non-smoker with incidentally detected left mid-zone chest opacity on X-ray.",
        "clinical_data": {
          "social_history": [
            {
              "category": "smoking",
              "status": "never"
            }
          ],
          "imaging": [
            {
              "type": "Radiography",
              "body_part": "Chest",
              "modality": "X-ray",
              "finding": "left mid-zone chest opacity"
            }
          ]
        }
      }
    },
    {
      "id": "N2",
      "label": "Step 2",
      "customData": {
        "node_id": "B",
        "node_step_index": 1,
        "content": "CT-guided biopsy confirmed EGFR exon-21 mutation-positive adenocarcinoma (EGFR p.Leu858Arg).",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C0678222",
              "label": "Adenocarcinoma",
              "status": "active"
            }
          ],
          "imaging": [
            {
              "modality": "CT",
              "type": "Computed tomography",
              "finding": "EGFR exon-21 mutation-positive",
              "impression": "EGFR exon-21 mutation-positive adenocarcinoma"
            }
          ],
          "procedures": [
            {
              "name": "Biopsy",
              "approach": "percutaneous",
              "location": "Lung"
            }
          ]
        }
      }
    },
    {
      "id": "N3",
      "label": "Step 3",
      "customData": {
        "node_id": "C",
        "node_step_index": 2,
        "content": "Patient experienced partial seizures involving her left leg.",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C0036372",
              "label": "Seizures",
              "status": "active",
              "onset_date": null
            }
          ],
          "HPI": [
            {
              "summary": "Patient experienced partial seizures involving her left leg.",
              "duration": null,
              "onset": null,
              "progression": "sudden",
              "associated_symptoms": [],
              "alleviating_factors": [],
              "exacerbating_factors": []
            }
          ]
        }
      }
    },
    {
      "id": "N4",
      "label": "Step 4",
      "customData": {
        "node_id": "D",
        "node_step_index": 3,
        "content": "MRI revealed at least nine cerebral metastases, including right frontal and parietal, bilateral temporal and left lentiform nucleus masses.",
        "clinical_data": {
          "imaging": [
            {
              "type": "C4721468",
              "body_part": "C1296340",
              "modality": "MRI",
              "finding": "cerebral metastases",
              "impression": "at least nine cerebral metastases, including right frontal and parietal, bilateral temporal and left lentiform nucleus masses."
            }
          ]
        }
      }
    },
    {
      "id": "N5",
      "label": "Step 5",
      "customData": {
        "node_id": "E",
        "node_step_index": 4,
        "content": "Diagnosis of metastatic EGFR mutation-positive lung adenocarcinoma, stage IVB (T2aN1M1c).",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C34",
              "label": "Lung cancer",
              "status": "active"
            },
            {
              "code": "C80",
              "label": "Metastatic cancer",
              "status": "active"
            }
          ]
        }
      }
    },
    {
      "id": "N6",
      "label": "Step 6",
      "customData": {
        "node_id": "F",
        "node_step_index": 5,
        "content": "Patient started on erlotinib 150 mg daily and dexamethasone 2 mg daily, along with antiepileptic therapy with phenytoin.",
        "clinical_data": {
          "medications": [
            {
              "drug": "C0974248",
              "dosage": "150 mg",
              "frequency": "daily",
              "modality": "oral",
              "start_date": null,
              "end_date": null,
              "indication": null
            },
            {
              "drug": "C0011872",
              "dosage": "2 mg",
              "frequency": "daily",
              "modality": "oral",
              "start_date": null,
              "end_date": null,
              "indication": null
            },
            {
              "drug": "C0031722",
              "dosage": null,
              "frequency": null,
              "modality": "oral",
              "start_date": null,
              "end_date": null,
              "indication": null
            }
          ]
        }
      }
    },
    {
      "id": "N7",
      "label": "Step 7",
      "customData": {
        "node_id": "G",
        "node_step_index": 6,
        "content": "Approximately 5 weeks into treatment, the patient re-presented with elevated liver enzymes, leading to cessation of erlotinib and switch from phenytoin to brivaracetam.",
        "clinical_data": {
          "medications": [
            {
              "drug": "C0031848",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            },
            {
              "drug": "C0031407",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            },
            {
              "drug": "brivaracetam",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            }
          ],
          "labs": [
            {
              "test": "C0152054",
              "value": null,
              "unit": null,
              "flag": "abnormal",
              "reference_range": null,
              "timestamp": null
            }
          ]
        }
      }
    },
    {
      "id": "N8",
      "label": "Step 8",
      "customData": {
        "node_id": "H",
        "node_step_index": 7,
        "content": "Ten days after medication change, the patient developed intermittent left facial twitching, followed by hypogeusia the next day, and then left and right facial droop the following day, resulting in inability to close her eyes, dysarthria, and drooling.",
        "clinical_data": {
          "HPI": [
            {
              "summary": "Patient developed intermittent left facial twitching, followed by hypogeusia, and then left and right facial droop, resulting in inability to close her eyes, dysarthria, and drooling.",
              "onset": "Ten days after medication change",
              "progression": "sudden",
              "associated_symptoms": [
                "Facial twitching",
                "Hypogeusia",
                "Facial droop",
                "Inability to close eyes",
                "Dysarthria",
                "Drooling"
              ]
            }
          ]
        }
      }
    },
    {
      "id": "N9",
      "label": "Step 9",
      "customData": {
        "node_id": "I",
        "node_step_index": 8,
        "content": "Cranial nerve examination demonstrated complete (House-Brackmann grade VI) weakness of all branches of the left facial nerve and severe (House-Brackmann grade V) weakness of the right facial nerve with hypogeusia on direct testing. No hypoacusis or hyperacusis was noted and no other cranial nerve, peripheral neurological or cerebellar abnormality seen. Bilateral facial nerve palsy was suspected.",
        "clinical_data": {
          "mental_status": [
            {
              "domain": "speech",
              "finding": "hypogeusia",
              "timestamp": null
            }
          ],
          "diagnoses": [
            {
              "code": "G51.0",
              "label": "Bilateral facial nerve palsy",
              "status": "suspected",
              "onset_date": null
            }
          ],
          "HPI": [
            {
              "summary": "Complete weakness of all branches of the left facial nerve and severe weakness of the right facial nerve",
              "duration": null,
              "onset": null,
              "progression": "unknown",
              "associated_symptoms": [],
              "alleviating_factors": [],
              "exacerbating_factors": []
            }
          ]
        }
      }
    },
    {
      "id": "N10",
      "label": "Step 10",
      "customData": {
        "node_id": "J",
        "clinical_data": {}
      }
    }
  ],
  "edges": [
    {
      "from": "N1",
      "to": "N2",
      "data": {
        "edge_id": "A_to_B",
        "branch_flag": true,
        "content": "From incidentally detected left mid-zone chest opacity on X-ray to CT-guided biopsy confirming EGFR exon-21 mutation-positive adenocarcinoma (EGFR p.Leu858Arg)."
      }
    },
    {
      "from": "N2",
      "to": "N3",
      "data": {
        "edge_id": "B_to_C",
        "branch_flag": true,
        "content": "From EGFR exon-21 mutation-positive adenocarcinoma to patient experiencing partial seizures involving her left leg."
      }
    },
    {
      "from": "N3",
      "to": "N4",
      "data": {
        "edge_id": "C_to_D",
        "branch_flag": true,
        "content": "From partial seizures involving her left leg to MRI revealing at least nine cerebral metastases, including right frontal and parietal, bilateral temporal and left lentiform nucleus masses."
      }
    },
    {
      "from": "N4",
      "to": "N5",
      "data": {
        "edge_id": "D_to_E",
        "branch_flag": true,
        "content": "From MRI revealing at least nine cerebral metastases to diagnosis of metastatic EGFR mutation-positive lung adenocarcinoma, stage IVB (T2aN1M1c)."
      }
    },
    {
      "from": "N5",
      "to": "N6",
      "data": {
        "edge_id": "E_to_F",
        "branch_flag": true,
        "content": "From diagnosis of metastatic EGFR mutation-positive lung adenocarcinoma, stage IVB (T2aN1M1c) to patient started on erlotinib 150 mg daily and dexamethasone 2 mg daily, along with antiepileptic therapy with phenytoin.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "C0974248",
            "C0011872",
            "C0031722"
          ],
          "change_type": "addition",
          "target_domain": "medication"
        }
      }
    },
    {
      "from": "N6",
      "to": "N7",
      "data": {
        "edge_id": "F_to_G",
        "branch_flag": true,
        "content": "From erlotinib, dexamethasone, and phenytoin to elevated liver enzymes, leading to cessation of erlotinib and switch from phenytoin to brivaracetam.",
        "transition_event": {
          "trigger_type": "lab_change",
          "trigger_entities": [
            "C0152054"
          ],
          "change_type": "escalation",
          "target_domain": "lab"
        }
      }
    },
    {
      "from": "N7",
      "to": "N8",
      "data": {
        "edge_id": "G_to_H",
        "branch_flag": true,
        "content": "From elevated liver enzymes, cessation of erlotinib and switch from phenytoin to brivaracetam to intermittent left facial twitching, followed by hypogeusia the next day, and then left and right facial droop the following day, resulting in inability to close her eyes, dysarthria, and drooling.",
        "transition_event": {
          "trigger_type": "symptom_onset",
          "trigger_entities": [
            "facial twitching",
            "hypogeusia",
            "facial droop",
            "inability to close eyes",
            "dysarthria",
            "drooling"
          ],
          "change_type": "addition",
          "target_domain": "symptom"
        }
      }
    },
    {
      "from": "N8",
      "to": "N9",
      "data": {
        "edge_id": "H_to_I",
        "branch_flag": true,
        "content": "From intermittent left facial twitching, followed by hypogeusia the next day, and then left and right facial droop the following day, resulting in inability to close her eyes, dysarthria, and drooling to cranial nerve examination demonstrating complete (House-Brackmann grade VI) weakness of all branches of the left facial nerve and severe (House-Brackmann grade V) weakness of the right facial nerve with hypogeusia on direct testing. No hypoacusis or hyperacusis was noted and no other cranial nerve, peripheral neurological or cerebellar abnormality seen. Bilateral facial nerve palsy was suspected.",
        "transition_event": {
          "trigger_type": "interpretation",
          "trigger_entities": [
            "G51.0"
          ],
          "change_type": "addition"
        }
      }
    }
  ]
}